<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical use of ginkgo biloba
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical use of ginkgo biloba
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical use of ginkgo biloba
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert B Saper, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joann G Elmore, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Seres, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sara Swenson, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 30, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ginkgo biloba, more commonly known as ginkgo, has been used medicinally for over 1000 years [
         <a href="#rid1">
          1
         </a>
         ]. The ginkgo tree is the world's oldest living tree species (
         <a class="graphic graphic_picture graphicRef57799" href="/z/d/graphic/57799.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
         Ginkgo represents one of the most studied and commonly used herbal remedies in the world. The National Health Interview Survey found that ginkgo was the ninth most popular natural product in the United States in 2012 [
         <a href="#rid2">
          2
         </a>
         ]. Over 400 clinical trials have been performed looking at a variety of medicinal properties and clinical uses. Ginkgo leaf extract has been used for its antioxidant properties; for a number of vascular problems; and for the treatment of memory loss, dementia, and macular degeneration [
         <a href="#rid3">
          3
         </a>
         ]. However, randomized trials evaluating the use of ginkgo biloba for the treatment and prevention of many diseases and conditions have failed to demonstrate consistent benefit.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PROPOSED MECHANISMS OF ACTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is thought that there are two main groups of active constituents responsible for ginkgo biloba's purported medicinal effects: terpene lactones and ginkgo flavone glycosides. These are present in varying concentrations in the leaf of the ginkgo tree [
         <a href="#rid1">
          1
         </a>
         ]. Approximately 40 different flavonoids have been isolated, including ginkgetin, bilobetin, and sciadopitysin [
         <a href="#rid4">
          4
         </a>
         ]. Terpenes isolated include a number of ginkgolides and diterpenes, most importantly the ginkgolides A, B, and C, along with bilobalide [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         The bioactive properties of ginkgo biloba extracts are varied. In animal studies, ginkgo biloba extract appears to decrease glucose utilization in brain areas mediating somatosensory processing and vigilance, inhibit stress-induced corticosteroid release [
         <a href="#rid6">
          6
         </a>
         ], and protect against age-related changes in the mouse hippocampus [
         <a href="#rid7">
          7
         </a>
         ]. In other animal studies, ginkgo biloba extracts have been demonstrated to inhibit nitric oxide [
         <a href="#rid8">
          8,9
         </a>
         ], induce vasodilation [
         <a href="#rid10">
          10
         </a>
         ], and reversibly inhibit brain monoamine oxidase A and B [
         <a href="#rid11">
          11
         </a>
         ], and they may act as scavengers for free radicals [
         <a href="#rid12">
          12
         </a>
         ], which are possible mediators of the lipid peroxidation and cell damage observed in Alzheimer disease [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         In in vitro studies, the terpene lactones inhibit the binding of platelet-activating factor (PAF) to its membrane receptor [
         <a href="#rid14">
          14
         </a>
         ]. In addition, ginkgo biloba demonstrates antioxidant properties [
         <a href="#rid15">
          15
         </a>
         ] and inhibits acetylcholinesterase [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PROPOSED INDICATIONS AND CLINICAL TRIALS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of studies for the clinical use of ginkgo biloba are for the treatment and prevention of memory issues, cognitive impairment, or dementia.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Dementia, cognitive impairment, memory enhancement
         </span>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data on the efficacy of ginkgo biloba extract for the treatment of Alzheimer or vascular dementia are mixed [
         <a href="#rid17">
          17-22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5073.html" rel="external">
          "Treatment of Alzheimer disease"
         </a>
         .)
        </p>
        <p>
         Although a small 1997 trial including adults with dementia (Alzheimer disease and vascular dementia) suggested that ginkgo biloba could prevent short-term cognitive deterioration [
         <a href="#rid21">
          21
         </a>
         ], in subsequent, higher-quality trials, results were inconsistent in terms of beneficial effects on cognition, function, mood, and caregiver stress. In a systematic review including trials of ginkgo for cognitive impairment and dementia, three of the four trials did not find a benefit of ginkgo over placebo [
         <a href="#rid23">
          23
         </a>
         ]. Adverse events for ginkgo and placebo were similar.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ginkgo biloba appears to be ineffective in preventing progression to dementia, both in older adults with normal cognition and in those with mild cognitive impairment (MCI) [
         <a href="#rid24">
          24-26
         </a>
         ]. In addition, ginkgo does not enhance memory in cognitively normal adults [
         <a href="#rid27">
          27,28
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Ginkgo Evaluation of Memory (GEM) study was a large, multicenter trial that randomly assigned over 3000 adults ages 75 and older (approximately 15 percent with MCI at baseline) to ginkgo biloba extract 120 mg twice daily or placebo [
         <a href="#rid29">
          29
         </a>
         ]. Ginkgo biloba did not reduce the risk of dementia in cognitively normal adults or in those with MCI at six years.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a small trial including 230 cognitively intact adults over age 60 years, ginkgo biloba extract did not show a beneficial effect for memory enhancement [
         <a href="#rid27">
          27
         </a>
         ]. Among participants receiving ginkgo biloba 40 mg three times daily for six weeks, there was no improvement in memory (as measured by standard neuropsychological tests, self-reported memory function, or global rating by spouses, friends, and relatives) compared with placebo. The ginkgo content of the preparation was not verified.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In another small trial including 214 patients with memory impairment from a variety of causes, participants received extract of ginkgo biloba (EGb) 761 (at a high dose of 240 mg or a low dose of 160 mg) or placebo for 24 weeks [
         <a href="#rid26">
          26
         </a>
         ]. There was no improvement in memory function with ginkgo compared with placebo.
        </p>
        <p>
        </p>
        <p>
         Other studies have found contradictory results [
         <a href="#rid18">
          18,30-34
         </a>
         ]. However, most of these studies were small, and the beneficial effects did not cover a broad range of findings nor were they consistent. In one randomized trial including 118 people over age 84, there was a nonstatistically significant trend toward less cognitive decline with ginkgo, but also an increased incidence of strokes [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Other disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ginkgo biloba has been evaluated in the treatment of other disorders, but the trials are small and high-quality evidence of efficacy for the treatment of most conditions is lacking.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Psychiatric disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ginkgo biloba has been studied as a treatment for depression:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One small study including 40 older adult patients with depression compared treatment with ginkgo biloba extract with placebo [
         <a href="#rid36">
          36
         </a>
         ]. The average total score on the Hamilton Depression Scale after four weeks fell significantly in those treated with ginkgo biloba extract compared with placebo.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a small double-blind trial including 27 patients, ginkgo was not effective in preventing seasonal affective disorder [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3423433280">
         <span class="h3">
          Movement disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ginkgo biloba may be helpful in reducing antipsychotic-induced tardive dyskinesia, although high-quality data are limited. This is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4908.html" rel="external">
          "Tardive dyskinesia: Prevention, treatment, and prognosis", section on 'Other drug treatments'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Antidepressant-associated sexual dysfunction
         </span>
         <span class="headingEndMark">
          —
         </span>
         In an open-label trial (in which study participants and researchers are unblinded as to which treatment individuals receive) including 63 adults with selective serotonin reuptake inhibitor (SSRI)-associated sexual dysfunction, 84 percent of patients reported improvement after four weeks of treatment with ginkgo biloba extract [
         <a href="#rid38">
          38
         </a>
         ]. However, in two small randomized trials including patients with SSRI-associated sexual dysfunction, treatment with ginkgo failed to show benefits compared with placebo [
         <a href="#rid39">
          39,40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Vertigo
         </span>
         <span class="headingEndMark">
          —
         </span>
         In one small trial including 70 patients with recent-onset vertigo of undetermined etiology, the use of ginkgo biloba extract reduced vertigo symptoms compared with placebo (47 versus 18 percent, respectively) [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Vitiligo
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is limited evidence that ginkgo may be effective in the management of vitiligo [
         <a href="#rid42">
          42,43
         </a>
         ]; this is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/106619.html" rel="external">
          "Vitiligo: Management and prognosis", section on 'Dietary supplements'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Ophthalmic conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         A 2013 systematic review identified two small six-month trials for macular degeneration, one comparing ginkgo biloba extract with placebo (n = 20) and the other comparing two different doses of the extract (n = 99); the results were not pooled [
         <a href="#rid44">
          44
         </a>
         ]. Although there was some suggestion of benefit in these trials, larger and longer trials are necessary to assess ginkgo's efficacy in the treatment of macular degeneration.
        </p>
        <p>
         In a small trial, ginkgo biloba extract improved visual field test results in some patients with normal-tension glaucoma [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H83976928">
         <span class="h3">
          Peripheral vascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is evidence that ginkgo is not effective for claudication in patients with peripheral vascular disease [
         <a href="#rid46">
          46-48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8210.html" rel="external">
          "Management of claudication due to peripheral artery disease", section on 'Ineffective'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Altitude sickness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most studies have found that ginkgo biloba does not prevent altitude sickness symptoms [
         <a href="#rid49">
          49-52
         </a>
         ]. In a network meta-analysis, ginkgo alone or as an adjunct to
         <a class="drug drug_general" data-topicid="9268" href="/z/d/drug information/9268.html" rel="external">
          acetazolamide
         </a>
         was not beneficial in preventing acute mountain sickness [
         <a href="#rid52">
          52
         </a>
         ]. However, in an earlier small trial not included in the meta-analysis involving 44 Himalayan mountain climbers, those treated with ginkgo biloba extract developed fewer mountain sickness symptoms than climbers taking placebo [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Tinnitus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite the common use of ginkgo for the treatment of tinnitus, well-designed studies do not support efficacy for this disorder. A systematic review of 12 trials found a high risk of bias due to inadequate reporting of blinding, treatment allocation, outcome heterogeneity, and selection bias. No meaningful conclusions could be made regarding the efficacy and safety of ginkgo for tinnitus [
         <a href="#rid53">
          53
         </a>
         ]. The treatment of tinnitus is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6856.html" rel="external">
          "Treatment of tinnitus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          SAFETY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ginkgo biloba extract generally appears to be safe and well-tolerated when used in standard doses (see
         <a class="local">
          'Dose'
         </a>
         below) in clinical trials lasting up to one year [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2124495244">
         <span class="h2">
          Adverse effects
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bleeding risk
         </strong>
         – There are several case reports of bleeding associated with ginkgo extracts [
         <a href="#rid54">
          54
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Combined use of high-dose
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         (325 mg daily) and ginkgo resulted in spontaneous bleeding into the anterior chamber of the eye [
         <a href="#rid55">
          55
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Spontaneous bilateral subdural hematoma with a prolonged bleeding time [
         <a href="#rid56">
          56
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chronic left frontal subdural hematoma [
         <a href="#rid57">
          57
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Subarachnoid hemorrhage [
         <a href="#rid58">
          58,59
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bilateral hematoma after rhytidoplasty and blepharoplasty [
         <a href="#rid60">
          60
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gastrointestinal bleeding and epistaxis associated with concomitant use of selective serotonin reuptake inhibitors (SSRIs) [
         <a href="#rid61">
          61
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, in a meta-analysis including 18 randomized trials and almost 2000 patients, there was no significant effect of ginkgo biloba on platelet aggregation, prothrombin time, or activated partial thromboplastin time [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other
         </strong>
         – Mild adverse effects include gastrointestinal upset and headaches [
         <a href="#rid1">
          1,63
         </a>
         ]. In addition, ingestion of ginkgo's non-leaf parts (eg, seed, fruit, or nut) can result in allergic reactions including blisters, erythema, and itching [
         <a href="#rid64">
          64-66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1293097807">
         <span class="h2">
          Contraindications
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Caution should be exercised with ginkgo in patients with bleeding disorders or those who take anticoagulant drugs. The risk of spontaneous bleeding may be increased when ginkgo biloba extract is combined with nonsteroidal antiinflammatory drugs (NSAIDs) and anticoagulants such as heparin or
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         [
         <a href="#rid1">
          1
         </a>
         ]. Analysis of a large database using natural language processing identified 11,003 patients who used ginkgo and warfarin concurrently. Compared with users of warfarin only, the ginkgo and warfarin group had an increased risk of an adverse bleeding event (hazard ratio 1.38, 95% CI 1.20-1.58) [
         <a href="#rid67">
          67
         </a>
         ]. Concomitant use of ginkgo with these agents should be avoided.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Episodes of serious bleeding from the use of ginkgo and low-dose (81 mg daily)
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         prophylaxis have not been reported; although this combination is likely safe, caution should be exercised.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, caution should be used when ginkgo is combined with other herbs believed to increase bleeding (eg, garlic, ginseng, ginger).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Few data exist about the risk of perioperative complications due to ginkgo use. Based on a literature review, some experts recommended that, because of the potential bleeding risk associated with ginkgo, it should be discontinued at least three days prior to a planned surgical procedure [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a lack of data regarding use in pregnancy and lactation; due to absent safety information, ginkgo should not be used in this population [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There are case reports of seizure associated with ginkgo use [
         <a href="#rid69">
          69-71
         </a>
         ]. Whether ginkgo lowers seizure threshold is uncertain, however, ginkgo should be used with caution in patients with seizure disorders.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Potential interactions
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The major components of ginkgo biloba preparations (terpenes, flavonol glycosides) do not significantly inhibit human cytochrome P450 isoforms in vitro [
         <a href="#rid72">
          72
         </a>
         ]. However, other components of ginkgo (flavonol aglycones, the bioflavonoid amentoflavone) do inhibit CYP1A2 and CYP3A4. The clinical importance of these potential interactions is uncertain.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ginkgo biloba extract in high doses may theoretically potentiate the effects of monoamine oxidase inhibitors (MAOIs) due to the inhibition of the uptake of serotonin and dopamine [
         <a href="#rid73">
          73
         </a>
         ]. One study showed reversible inhibition of monoamine oxidase in rats fed ginkgo extract [
         <a href="#rid74">
          74
         </a>
         ]. This has led some to caution against the use of ginkgo biloba extract in patients taking other antidepressants due to the potential risk of precipitating serotonin syndrome (agitation, hyperthermia, diaphoresis, tachycardia, and neuromuscular disturbances including rigidity) (see
         <a class="medical medical_review" href="/z/d/html/301.html" rel="external">
          "Serotonin syndrome (serotonin toxicity)", section on 'Pharmacology and cellular toxicology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2738.html" rel="external">
          "Drug fever", section on 'Serotonin syndrome'
         </a>
         ). There are no reports of serotonin syndrome in studies of ginkgo for SSRI-induced sexual dysfunction. However, patients should be advised of the potential for these interactions, although the true risk is unknown [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ginkgo 90 mg daily did not show any adverse effects on the pharmacokinetics of
         <a class="drug drug_general" data-topicid="9383" href="/z/d/drug information/9383.html" rel="external">
          donepezil
         </a>
         5 mg daily when administered together [
         <a href="#rid76">
          76
         </a>
         ]. Potential adverse or synergistic interactions with other medications used in treating dementia are unknown.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1433941167">
         <span class="h1">
          ADMINISTRATION
         </span>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Dose
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of the studies evaluating ginkgo extract utilized the standardized extract of ginkgo biloba (EGb) 761. EGb 761 is standardized to contain 24% flavonoid glycosides and 6% terpenoids [
         <a href="#rid77">
          77
         </a>
         ]. Typical dosages of EGb 761 used in studies and recommended by manufacturers are 40 mg three times daily or 80 mg twice daily.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Standardization of available products
         </span>
         <span class="headingEndMark">
          —
         </span>
         Quality control of herbal and dietary supplements, including ginkgo biloba, is variable. Despite attempts by the US Food and Drug Administration to improve regulation of quality and safety standards for dietary supplements [
         <a href="#rid78">
          78
         </a>
         ], experts have criticized current standards as insufficient and enforcement activities as inadequate [
         <a href="#rid79">
          79,80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">
          "Overview of herbal medicine and dietary supplements", section on 'Regulation in the United States'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">
          "Overview of herbal medicine and dietary supplements", section on 'International regulation'
         </a>
         .)
        </p>
        <p>
         If patients choose to use ginkgo, they should be advised to use brands which have passed specified quality criteria by independent commercial laboratories such as
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.consumerlab.com%2Fbrands%2F&amp;token=Rti1NBSWdX%2F%2FH%2FlCKGrzlGMVGlCUrFHlUaCBsnmPKVvFpPS1ru3OiHJIvt4GgHbc&amp;TOPIC_ID=1387" target="_blank">
          ConsumerLab.com
         </a>
         or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usp.org%2Freference-standards&amp;token=lFzHfu5Xyr2WkFJhkf9tP1%2F57i7IEU7zSBlhoTl6LoNCKz8y0vWmrGLh2i3Z9jTV&amp;TOPIC_ID=1387" target="_blank">
          USP-verified dietary supplements
         </a>
         .
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ginkgo biloba, more commonly known as ginkgo, has been used medicinally for over 1000 years. Patients commonly use ginkgo for a wide range of conditions. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Randomized trials evaluating the use of ginkgo biloba for the treatment and prevention of many diseases and conditions have failed to demonstrate consistent benefit. (See
         <a class="local">
          'Proposed indications and clinical trials'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ginkgo is generally well tolerated, although case reports of bleeding complications suggest that it should not be used perioperatively or in patients with known bleeding disorders. In addition, ginkgo should be avoided or used with caution in patients receiving anticoagulants. (See
         <a class="local">
          'Safety'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Quality control of herbal and dietary supplements, including ginkgo biloba, is variable. If patients choose to use ginkgo, they should be advised to use brands that have passed specified quality criteria by independent commercial laboratories. (See
         <a class="local">
          'Standardization of available products'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Ginkgo biloba. In: Natural Medicines, Therapeutic Research Center Healthcare 2020. Available at: https://naturalmedicines.therapeuticresearch.com/ (Accessed on August 10, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 2008; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin JH. Evaluating the alternatives. JAMA 1998; 279:706.
          </a>
         </li>
         <li class="breakAll">
          Newall CA, Anderson LA, Phillipson JD. Ginkgo Biloba. In: Herbal Medicines: A Guide for Health-Care Professionals, Pharmaceutical Press, London 1996. p.138.
         </li>
         <li class="breakAll">
          Brown D, Gaby A, Reichert R, et al. Clinical Applications of Natural Medicine. In: Dementia and Age-Related Cognitive Decline, Natural Product Research Consultants, Seattle 1997. p.10.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marcilhac A, Dakine N, Bourhim N, et al. Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat. Life Sci 1998; 62:2329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barkats M, Venault P, Christen Y, Cohen-Salmon C. Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sci 1995; 56:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen X, Salwinski S, Lee TJ. Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway. Clin Exp Pharmacol Physiol 1997; 24:958.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kobuchi H, Droy-Lefaix MT, Christen Y, Packer L. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997; 53:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kubota Y, Tanaka N, Umegaki K, et al. Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level. Life Sci 2001; 69:2327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996; 58:1315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res 1994; 635:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994; 77:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maerz S, Liu CH, Guo W, Zhu YZ. Anti-ischaemic effects of bilobalide on neonatal rat cardiomyocytes and the involvement of the platelet-activating factor receptor. Biosci Rep 2011; 31:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Köse K, Doğan P. Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761). J Int Med Res 1995; 23:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang L, Li D, Cao F, et al. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations. Comb Chem High Throughput Screen 2018; 21:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994; 151:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Semlitsch HV, Anderer P, Saletu B, et al. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment. Pharmacopsychiatry 1995; 28:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanowski S, Herrmann WM, Stephan K, et al. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996; 29:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. Curr Med Res Opin 1991; 12:350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997; 278:1327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider LS, DeKosky ST, Farlow MR, et al. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type. Curr Alzheimer Res 2005; 2:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2009; :CD003120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butler M, Nelson VA, Davila H, et al. Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review. Ann Intern Med 2018; 168:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snitz BE, O'Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009; 302:2663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Dongen MC, van Rossum E, Kessels AG, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000; 48:1183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solomon PR, Adams F, Silver A, et al. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288:835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlson JJ, Farquhar JW, DiNucci E, et al. Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults. J Am Diet Assoc 2007; 107:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008; 300:2253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992; 340:1136.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmidt U, Rabinovici K, Lande S. Einfluss eines Ginkgo biloba Specialextraktes auf doe befomdlickeit bei zerebraler Onsufficizienz. Muench Med Wochenschr 1991; 133(Suppl 1):S15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruchert E, Heinrich SE, Ruf-Kohler P. Wirksamkeit von LI 1370 bei alteren Patienten mit Himleistungsschwache. Multizentrische doppelblindstudie des fachverbandes Deutsher Allegemeinaezte. Muench Med Wochenschr 1991; 133(Suppl 1):S9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wesnes K, et al. A double-blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Hum Psychopharmacol 1987; 2:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopfenmüller W. [Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age]. Arzneimittelforschung 1994; 44:1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodge HH, Zitzelberger T, Oken BS, et al. A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 2008; 70:1809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schubert H, Halama P. Depressive episode primarily unresponsive to therapy in elderly patients: Efficacy of Ginkgo biloba (EGb 761) in combination with antidepressants. Geriatr Forsch 1993; 3:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lingaerde O, Føreland AR, Magnusson A. Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial. Acta Psychiatr Scand 1999; 100:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998; 24:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 2004; 19:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang BJ, Lee SJ, Kim MD, Cho MJ. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol 2002; 17:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haguenauer JP, Cantenot F, Koskas H, Pierart H. [Treatment of equilibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study]. Presse Med 1986; 15:1569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 2003; 28:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med 2011; 11:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans JR. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst Rev 2013; :CD001775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003; 110:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           2011 WRITING GROUP MEMBERS, 2005 WRITING COMMITTEE MEMBERS, ACCF/AHA TASK FORCE MEMBERS. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124:2020.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicolaï SP, Kruidenier LM, Bendermacher BL, et al. Ginkgo biloba for intermittent claudication. Cochrane Database Syst Rev 2013; :CD006888.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roncin JP, Schwartz F, D'Arbigny P. EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat Space Environ Med 1996; 67:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gertsch JH, Basnyat B, Johnson EW, et al. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004; 328:797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chow T, Browne V, Heileson HL, et al. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med 2005; 165:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sridharan K, Sivaramakrishnan G. Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials. Ann Med 2018; 50:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sereda M, Xia J, Scutt P, et al. Ginkgo biloba for tinnitus. Cochrane Database Syst Rev 2022; 11:CD013514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med 2005; 20:657.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 336:1108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46:1775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilbert GJ. Ginkgo biloba. Neurology 1997; 48:1137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998; 352:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pedroso JL, Henriques Aquino CC, Escórcio Bezerra ML, et al. Ginkgo biloba and cerebral bleeding: a case report and critical review. Neurologist 2011; 17:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Destro MW, Speranzini MB, Cavalheiro Filho C, et al. Bilateral haematoma after rhytidoplasty and blepharoplasty following chronic use of Ginkgo biloba. Br J Plast Surg 2005; 58:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woroń J, Siwek M. Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts. Psychiatr Pol 2018; 52:983.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy 2011; 31:490.
          </a>
         </li>
         <li class="breakAll">
          Pizzorno JE, Murray MT. A textbook of natural medicine, John Bastyr College Publications, Seattle 1985.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegers CP. Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 1999; 6:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pennisi RS. Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba. Med J Aust 2006; 184:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasegawa S, Oda Y, Ichiyama T, et al. Ginkgo nut intoxication in a 2-year-old male. Pediatr Neurol 2006; 35:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoddard GJ, Archer M, Shane-McWhorter L, et al. Ginkgo and Warfarin Interaction in a Large Veterans Administration Population. AMIA Annu Symp Proc 2015; 2015:1174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stohs SJ, Dudrick SJ. Nutritional supplements in the surgical patient. Surg Clin North Am 2011; 91:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gregory PJ. Seizure associated with Ginkgo biloba? Ann Intern Med 2001; 134:344.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing 2001; 30:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba. J Anal Toxicol 2005; 29:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Moltke LL, Weemhoff JL, Bedir E, et al. Inhibition of human cytochromes P450 by components of Ginkgo biloba. J Pharm Pharmacol 2004; 56:1039.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramassamy C, Christen Y, Clostre F, Costentin J. The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies. J Pharm Pharmacol 1992; 44:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rojas P, Rojas C, Ebadi M, et al. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity. Neurochem Res 2004; 29:1417.
          </a>
         </li>
         <li class="breakAll">
          Herb Contraindications and Drug Interactions, 2nd ed, Brinker F (Ed), Eclectic Medical Publications, Sandy, OR 1998.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yasui-Furukori N, Furukori H, Kaneda A, et al. The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil. J Clin Pharmacol 2004; 44:538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998; 7:523.
          </a>
         </li>
         <li class="breakAll">
          US Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, MD, on the agency’s new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight. Available at: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-agencys-new-efforts-strengthen-regulation-dietary (Accessed on August 08, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen PA. Assessing supplement safety--the FDA's controversial proposal. N Engl J Med 2012; 366:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The Lancet . Dietary supplement regulation: FDA's bitter pill. Lancet 2019; 393:718.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1387 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://naturalmedicines.therapeuticresearch.com/" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Ginkgo biloba. In: Natural Medicines, Therapeutic Research Center Healthcare 2020. Available at: https://naturalmedicines.therapeuticresearch.com/ (Accessed on August 10, 2020).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19361005" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Complementary and alternative medicine use among adults and children: United States, 2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9496992" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Evaluating the alternatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9496992" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Evaluating the alternatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9496992" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Evaluating the alternatives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9651122" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7823780" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9406663" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Extracts of Ginkgo biloba and ginsenosides exert cerebral vasorelaxation via a nitric oxide pathway.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9113109" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11681620" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8614288" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Extracts of Ginkgo biloba leaves inhibit monoamine oxidase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8173947" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8004671" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hydrogen peroxide mediates amyloid beta protein toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21391918" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Anti-ischaemic effects of bilobalide on neonatal rat cardiomyocytes and the involvement of the platelet-activating factor receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7774754" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29173156" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8109647" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7491367" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8741021" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2044394" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9343463" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16375657" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19160216" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Ginkgo biloba for cognitive impairment and dementia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29255909" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20040554" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11037003" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12186600" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Ginkgo for memory enhancement: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17324660" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Safety and efficacy of a ginkgo biloba-containing dietary supplement on cognitive function, quality of life, and platelet function in healthy, cognitively intact older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19017911" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Ginkgo biloba for prevention of dementia: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1359218" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Einfluss eines Ginkgo biloba Specialextraktes auf doe befomdlickeit bei zerebraler Onsufficizienz
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Wirksamkeit von LI 1370 bei alteren Patienten mit Himleistungsschwache. Multizentrische doppelblindstudie des fachverbandes Deutsher Allegemeinaezte
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : A double-blind placebo-controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7986236" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : [Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18305231" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Depressive episode primarily unresponsive to therapy in elderly patients: Efficacy of Ginkgo biloba (EGb 761) in combination with antidepressants
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10442441" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9611693" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Ginkgo biloba for antidepressant-induced sexual dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15378664" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12404672" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2947102" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : [Treatment of equilibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12780716" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21406109" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23440785" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Ginkgo biloba extract for age-related macular degeneration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12578781" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16549646" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21959305" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23744597" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Ginkgo biloba for intermittent claudication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8725471" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15070635" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15710792" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29166795" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Pharmacological interventions for preventing acute mountain sickness: a network meta-analysis and trial sequential analysis of randomized clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36383762" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Ginkgo biloba for tinnitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16050865" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9091822" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Spontaneous hyphema associated with ingestion of Ginkgo biloba extract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8649594" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9109922" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9800751" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Subarachnoid haemorrhage associated with Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21364361" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Ginkgo biloba and cerebral bleeding: a case report and critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15629177" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Bilateral haematoma after rhytidoplasty and blepharoplasty following chronic use of Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30659561" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21923430" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21923430" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10589448" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Cytotoxicity of alkylphenols from Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16768668" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16996402" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Ginkgo nut intoxication in a 2-year-old male.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26958257" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Ginkgo and Warfarin Interaction in a Large Veterans Administration Population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21787976" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Nutritional supplements in the surgical patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11182853" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Seizure associated with Ginkgo biloba?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11742783" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Ginkgo biloba precipitating epileptic seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16419414" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Fatal seizures due to potential herb-drug interactions with Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15285849" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Inhibition of human cytochromes P450 by components of Ginkgo biloba.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1361545" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15202774" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15202774" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15102875" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9821826" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : A review of 12 commonly used medicinal herbs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9821826" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : A review of 12 commonly used medicinal herbs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22276780" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Assessing supplement safety--the FDA's controversial proposal.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30799001" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Dietary supplement regulation: FDA's bitter pill.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
